The nomination of ISM9546 marks a significant milestone for generative artificial intelligence,
The recent events at the Irkutsk Anti-Plague Research Institute demonstrate the significant
By mimicking the bioelectric environment of living bone, this new composite material encourages the body to repair itself using internal biomechanical forces. Orthopedic surgeons have long encountered severe difficulties when treating large segmental bone defects, which are substantial gaps in
The movement toward off-the-shelf immunotherapy is solving the scalability issues that have long limited the reach of personalized autologous cellular treatments in oncology clinics. While chimeric antigen receptor (CAR) T-cell therapies have established a foundational success in treating
With a focus on advanced machine learning, Isomorphic Labs is attempting to cut years off the
The volumetric extent of ground-glass opacities and consolidations serves as a critical marker for
The partnership between Eli Lilly and NVIDIA to build a supercomputer capable of running trillions of molecular simulations is a signal that biopharma’s approach to drug discovery is changing at a s…
The move from research-level discovery to established clinical use is a critical juncture that
The biopharma playbook is being actively rewritten. After years of chasing breakthrough science at
In 2026, boards and customers are asking a direct question: can promising science be turned into
The pharmaceutical sector is entering a decisive phase as obesity therapeutics gain more ground as
The integration of NVIDIA computing into Danaher's diagnostic portfolio addresses the growing gap between rapid AI hypothesis generation and the slower pace of physical experimentation. As biological research scales in complexity, the traditional manual approach to laboratory work has become a
BullFrog AI is analyzing neuropsychiatric multi-omic data to identify novel targets for major
Research indicates that high-value algorithms developed in academic settings often fail to diffuse
